CLDI Earnings
Calidi Biotherapeutics Inc
$
5.010
- Overview
- Forecast
- Valuation
- Earnings
Earning Analysis
Welcome to our in-depth analysis of Calidi Biotherapeutics Inc(CLDI) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Calidi Biotherapeutics Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency:
Actual
Estimate
Surprise Analysis
| - | 2024-11-19 | After Hours | - | - | - | - | - | - | -4.58 | -19.58 |
| - | 2024-08-20 | After Hours | - | - | - | - | - | - | -1.30 | -26.38 |
| FY2024Q1 | 2024-05-14 | - | -0.27 | -0.20 | +25.93 | - | - | - | +1.80 | +11.71 |
CLDI Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Calidi Biotherapeutics Inc reported performance for , announced on 2024-11-19. The company achieved an EPS of , compared to analyst estimates of by % . Revenue for the quarter reached 0.00 compared to expectations of 0.00 by % .
The stock price reacted with a -4.58% one-day change and a -19.58% five-day change following the earnings release. These movements reflect market reaction in Calidi Biotherapeutics Inc growth trajectory and strategic initiatives.
CLDI Earnings Forecast
Looking ahead, Calidi Biotherapeutics Inc(CLDI) remains a focal point for investors seeking growth opportunities. Analyst forecasts for project quarter revenue of and an EPS of .
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for have been Go Down by -5.93%, while EPS estimates have been No Change by %. For the upcoming , revenue estimates have been adjusted No Change by % . These revisions correlate with a % change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Calidi Biotherapeutics Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between CLDI's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Stock Price
Go Down
-5.93%
In Past 3 Month
1Y
3Y
5Y
Fiscal Period
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-:0
--
EPS Estimate-:0
—
Stock Price5.01
CLDI Revenue and EPS Performance: A Historical Perspective
Calidi Biotherapeutics Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
(2024-11-19,After Hours):
EPS: (Actual) vs. (Estimate) (%)
Revenue: 0.00 (Actual) vs. 0.00 (Estimate) (%)
Price Reaction: -4.58%(1-Day), -19.58%(5-Day)
(2024-08-20,After Hours):
EPS: (Actual) vs. (Estimate) (%)
Revenue: 0.00 (Actual) vs. 0.00 (Estimate) (%)
Price Reaction: -1.30%(1-Day), -26.38%(5-Day)
FY2024Q1 (2024-05-14,):
EPS: -0.20 (Actual) vs.-0.27 (Estimate) (25.93%)
Revenue: 0.00 (Actual) vs. 0.00 (Estimate) (%)
Price Reaction: 1.80%(1-Day), 11.71%(5-Day)
Earnings Reaction
The chart below shows how CLDI performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CLDI sees a -14.23% change in stock price 10 days leading up to the earnings, and a -10.47% change 10 days following the report. On the earnings day itself, the stock moves by +1.20%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in , the stock changed -4.58% on the day following the earnings release and then changed by -19.17% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
No Data
People Also Watch
EQ
Equillium Inc
0.495
USD
-10.49%
TOON
Kartoon Studios Inc
0.684
USD
+3.33%
SIF
SIFCO Industries Inc
5.150
USD
+1.98%
SIDU
Sidus Space Inc
1.110
USD
-2.63%
KUKE
Kuke Music Holding Ltd
2.030
USD
-0.49%
TOMZ
TOMI Environmental Solutions Inc
1.020
USD
-0.49%
EPOW
Sunrise New Energy Co Ltd
0.890
USD
-0.11%
VSEE
Vsee Health Inc
1.320
USD
-3.65%
SPCB
Supercom Ltd
11.550
USD
+6.65%
SYNX
Silynxcom Ltd
1.760
USD
-2.22%
FAQ
What were the key highlights of CLDI’s latest earnings report for ?
CLDI reported its earnings on 2024-11-19, showcasing a revenue of 0.00 against an estimate of 0.00, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0 by 0% . The stock experienced a -4.58% price change on the earnings day and a -19.58% change over the next five days, reflecting market reactions to the results.
How did CLDI’s stock price react after the earnings release?
What are the revenue and EPS estimates for CLDI for undefined?
How does CLDI’s stock price correlate with earnings forecast revisions?
What should investors expect from CLDI’s next earnings report?